within Pharmacolibrary.Drugs.ATC.J;

model J02AB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.32,
    Cl             = 3.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,
    adminCount     = 1,
    Vd             = 0.00041999999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.014,
    Tlag           = 9.6
  );

  annotation(Documentation(
    info ="<html><body><p>Ketoconazole is an imidazole antifungal agent used primarily to treat systemic and topical fungal infections. It was formerly used as an oral agent but has largely been replaced by other antifungals due to its hepatic toxicity profile. Topical formulations remain in clinical use, but oral ketoconazole is rarely used today except in limited circumstances.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>DeVane, CL, &amp; Nemeroff, CB (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. <i>Clinical pharmacokinetics</i> 40(7) 509–522. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200140070-00003&quot;>10.2165/00003088-200140070-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11510628/&quot;>https://pubmed.ncbi.nlm.nih.gov/11510628</a></p></li><li><p>KuKanich, B, et al., &amp; Black, J (2017). The effects of ketoconazole and cimetidine on the pharmacokinetics of oral tramadol in greyhound dogs. <i>Journal of veterinary pharmacology and therapeutics</i> 40(6) e54–e61. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12424&quot;>10.1111/jvp.12424</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28603935/&quot;>https://pubmed.ncbi.nlm.nih.gov/28603935</a></p></li><li><p>Abbas, R, et al., &amp; Sonnichsen, D (2011). Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. <i>British journal of clinical pharmacology</i> 71(4) 522–527. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.2010.03845.x&quot;>10.1111/j.1365-2125.2010.03845.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21395644/&quot;>https://pubmed.ncbi.nlm.nih.gov/21395644</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J02AB02;
